Biktarvy, formally known as bictegravir sulfate, is a potent single-tablet regimen for controlling HIV infection. This drug unites three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the the viral ability to multiply within the body, considerably decreasing the viral quantity. For many individual